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Introduction: Generation of an expression clone that can produce the 
pharmaceutical proteins in an efficient and soluble form at high levels is 
considered as an important step in pharmaceutical industry. Recombination-
based cloning could be a quick and efficient way for generating expression 
vectors. Thus, both efficient and robust subcloning is vital for the construction 
of gene expression vectors. In this study, we used the traditional restriction 
enzyme-based cloning methods for generation of expression-ready clones by 
the most well-known commercial cloning technologies, Gateway. 
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Gateway cloning, the site-specific recombination system, 
is based on the robustly specific integration and excision 
reactions of bacteriophage λ into and out of the E. coli 
chromosome [1]. The Gateway cloning technology 
consists of two LR and BP recombination reactions. The 
BP reaction used to create an Entry clone by 
transferring DNA elements of interest in the Expression 
clone or the attB-flanked PCR product into a Donor 
vector. The LR reaction used to generate an Expression 
clone by recombination between attL and attR sites 
contained in the Entry vector (which is contained the 
gene for kanamycin resistance) and the Destination 
vector (which is contained all the necessary sequences 
for expression), respectively (Figure 1) [2]. It has been 
indicated that the Gateway system can provide an 
advance over classical restriction enzyme cloning by 
increasing the efficiency and reliability [3]. The 
Gateway cloning system is considered as a novel trend 
in molecular biology that eliminates the need for 
traditional cloning methods for transferring genes 
between vectors [4, 5]. In one study, adenovirus vectors 
containing the lumican gene had been constructed by 
Gateway cloning technology [6]. In another study, 
RNAi vectors, for SmNAC1 transcription factors of 
Salvia miltiorrhiza, had been constructed by Gateway 
technology. It has been proved that this technology 
could provide a rapid and highly efficient cloning 
method [7].  We created a PCR product, attB1- pSV40 - 
GFP- BGH polyA- attB2, to easily be cloned into 
pDONR™ 221 Gateway vector in a single 
recombination reaction. 
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Figure 1. Schematic model of Gateway cloning system as well as the 
role of the classical restriction enzyme-based cloning methods in 
Gateway cloning system. 
 
2. Materials & Methods 
Strains, plasmids and culture media 
The expression cassette for GFP was prepared in 
pTracer-SV40 plasmid (Thermo Fisher Scientific). The 
sequence was sub-cloned from the pEGFP-N1 plasmid 
(Clonetech), into the pTracer-SV40 plasmid by PstI / 
NotI restriction enzymes. E. coli strain Top10 F' 
(Novagen) was used as the host to propagate plasmids. 
E. coli was cultured in LB agar and Broth (Bio Basic). 
Zeocin selection reagent was purchased from Thermo 
Fisher Scientific. PstI, NotI, and BpiI restriction 
enzymes were obtained from Fermentas. 
GFP cloning in the pTracer-SV40 expression 
plasmid  
The GFP gene was cloned into the expression plasmid 
pTracer-SV40 with PstI and NotI restriction enzymes, 
respectively. The pEGFP-N1 plasmid and the pTracer-
SV40 plasmid were double-digested with the PstI 
and ‎NotI restriction endonucleases for 16h at 37 °C. 
Then digested fragments were electrophoresed on the 1 
% agarose gel stained with ethidium bromide. 
Subsequently, the fragments were purified using the 
NucleoSpin® Gel and PCR Clean-up kit (MN) 
according to manufacturer's instructions. Ligation was 
performed by using T4 DNA ligase enzyme 
(Fermentas). 100 ng of purified double-digested of 
cloned pTracer-SV40 and 3 - 5 fold molar excess of 
insert (GFP) were incubated with T4 DNA ligase 
enzyme and 10X T4 DNA ligase buffer at 22 °C for 4 
hr. The recombinant plasmid was transformed into the 
competent Top10 F' by standard calcium chloride 
method. Transformants were selected on low salt LB-
agar medium containing Zeocin (25-50 µg /mL). A 
single colony of E. coli cells carrying the ligated 
plasmid was grown in 5 ml low salt LB medium 
containing Zeocin (25-50 µg /mL). Plasmid extraction 
was performed using the FavorPrep Plasmid Extraction 
Mini Kit (FAPDE050- Favorgen Biotec Corp). 
Subsequently clones containing ligated plasmid were 
screened with BpiI restriction enzyme . 
 
Amplification of attB1- pSV40 - GFP- BGH polyA- 
attB2 gene with PCR 
attB1- pSV40 - GFP- BGH polyA- attB2 gene was 
amplified by PCR using the following primers: attB1- 
pSV40 - GFP- BGH polyA - Fwd 5 -́
GGGACAAGTTTGTACAAAAAAGCAGGCT 
CGGCTGTGGAATGTG- 3΄ and attB2- pSV40 - GFP- 
BGH polyA -Rev 5΄ GGGG AC CAC TTT GTA CAA 
GAA AGC TGG GTA AGAGCCCACCGCATC-  3΄. 
The underlined bases show ‎ attB1 and ‎ attB2 sites, 
respectively and the PCR products were flanked by 
these sites. The PCR mixture consisted of 5 μL of 10 × 
PCR buffer, 2.5 mM MgCl2, 0.2 mM for each dNTP, 
250 nM for each primer, 1 μL of template DNA, and 5 
units of Pfu DNA polymerase (Fermentas) in the final 
volume of 50 μL. The amplification consisted of 35 
cycles on a thermocycler (Eppendorf) as follows: 
preliminary denaturation for 5 min at 95 °C followed by 
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25 cycles including denaturation for 1 min at 95 °C, 
annealing for 1 min at 53 °C and extension for 1 min at 
72 °C, and final extension for 10 min at 72 °C. PCR 
product fragment was electrophoresed on the 1% 
agarose gel and stained with ethidium bromide. After 
the PCR process, the amplified DNA fragments are 
size-separated by agarose gel electrophoresis and 
purified using the NucleoSpin® Gel and PCR Clean-up 
kit (MN). Then, the DNA fragment should be combined 
with a pDONR™ 221, attP1 and attP2 sequences 
containing vector, with BP Clonase II enzyme supplied 
by Jump-In™ TI™ Gateway® Vector Kit (A10896, 
Life Technologies).  Moreover, pDONR™ 221 could 
not be used to generate multi-fragment entry clones. 
 
3. Results 
In this study, we used classical cloning system to 
generate a suitable PCR product for Gateway® BP 
reaction with a donor vector (flanked by attP1 and attP2 
sites). Thus, the PCR product should be flanked by 
attB1 and attB2 sites.Generation of the attB1- pSV40 - 
GFP- BGH polyA- attB2 PCR product. 
Due to lack of promoter and polyadenylation sequences 
in Gateway cloning vectors, we designed the reporter 
gene, GFP, with SV40 promoter and BGH 
polyadenylation sequences. The GFP gene was sub-
cloned from the pEGFP-N1 vector, into the pTracer-
SV40 plasmid with PstI and NotI restriction enzymes 
(Figure 2, 3). In electrophoresis of cloned pTracer-SV40 
plasmid, two different bonds could be detected (2100 
and 2700 bp). pSV40 - GFP- BGH polyA gene was 
amplified by attB1- pSV40 - GFP- BGH polyA - Fwd 
and attB2- pSV40 - GFP- BGH polyA -Rev primers by 
addition of attB1 and attB2 sites. Successful 
amplification of 1300 bp of attB1- pSV40 - GFP- BGH 
polyA- attB2 gene was visualized on 1% agarose 
(Figure 4).  The suitable PCR product was generated to 
be cloned into the pDONR™ 221 plasmid.  
 
Figure 2. Agarose gel electrophoresis of digested pEGFP-N1 with PstI and NotI restriction enzymes. Lane 1 corresponds to undigested 
pEGFP-N1; Lanes 2 corresponds to digested pEGFP-N1 vector (700 bp GFP); Lane 3 shows 1kbp DNA Ladder (Fermentas). 
 
 
Figure 3. Agarose gel electrophoresis of digested pTracer-SV40 with BpiI restriction enzyme. Lane 1 corresponds to undigested the 
pTracer-SV40; Lanes 2 corresponds to digested pTracer-SV40 vector (2100 and 2700 bp); Lane 3 shows 1kbp DNA Ladder (Fermentas). 
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Figure 4. Agarose gel electrophoresis of amplified attB1- pSV40 - 
GFP- BGH polyA- attB2 (pTracer-SV40 plasmid). Lane 1 shows 
negative control; Lane 2 shows 1kbp DNA Ladder (Fermentas); Lane 
3 Shows amplified attB1- pSV40 - GFP- BGH polyA- attB2 gene. 
 
4. Discussion and Conclusion 
Traditional cloning requires the use of restriction 
enzymes, T4 DNA ligase, or alkaline phosphatase that 
could be expensive and need long-term optimization, 
while Gateway cloning system represents a fast, 
efficient, and robust cloning method for the generation 
of an over-expressed vector. The Gateway cloning 
system uses site-specific recombination to transfer DNA 
elements between vector backbones [8]. In one study, a 
construct (pDONR-R4-R3) was generated that can 
convert any available Gateway destination vector to a 
MultiSite Gateway vector in a single recombination 
reaction [9]. In this studies, the reporter gene (GFP) was 
first cloned into Multiple Cloning Site (MCS) of 
pTracer-SV40 plasmid. Promoter sequences (pSV40) 
were located directly upstream of cloned GFP and BGH 
polyA was located downstream of the reporter gene as 
polyadenylation site. Since Gateway cloning vectors do 
not have promoter and cannot be expressed without 
necessary sequences, and pTracer-SV40 plasmid 
contains GFP-Zeo sequence, we had to construct a 
standard Gateway cassette (attB1- pSV40 - GFP- BGH 
polyA- attB2) by PCR.  In conclusion, the creation of 
DNA constructs could be a rate-limiting step in 
biological experiments. Recombination cloning of 
single DNA segments by using the Gateway cloning 
system can provide an advance over classical restriction 
enzyme cloning due to its high efficiency and reliability. 
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